January 26, 2017
Over the last 18 months, an alarming number of medical device companies’ challenges with data security have been exposed. In 2015, Hospira’s LifeCare PCA3 and…
Posted by
September 15, 2016
Today, it’s rare to go a week without reading a story in the news about hackers finding and/or exploiting security vulnerabilities in a healthcare setting.…
Posted by
Good Start Genetics is setting the pace for carrier screening. Based on proprietary gene-sequencing technology, Good Start Genetics’ pre-pregnancy test is more accurate and comprehensive,…
Posted by
In the rush of the holidays, you may have missed some recent news from Safeguard Scientifics’ life sciences partner company Alverix. On December 20, 2011,…
Posted by
Recent news and predictions for venture capital have been anything but cheery. With a wobbly economy and uncertainty surrounding government reforms, investors are understandably cautious.…
Posted by
In the latest VentureView report, the National Venture Capital Association and Dow Jones & Co. reported that 63 percent of VCs think their portfolio companies…
Posted by
Safeguard Scientifics has a unique and consistent approach to putting capital to work in the life sciences sector. We target capital efficient diagnostic companies that…
Posted by
The convergence between life sciences and technology cannot be ignored. That’s why at Safeguard Scientifics, we consolidated of our life sciences and technology deal teams.…
Posted by
Ninety percent of migraine sufferers experience nausea, while 60 percent experience vomiting because of their migraine. As a result, today’s most common migraine treatments that…
Posted by
